- Sarepta to cut 500 jobs, add black-box warning on gene therapy Reuters
- Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label Sarepta Therapeutics
- Sarepta Soars as Gene Therapy Stays on Market With Warning Bloomberg
- Sarepta pivots to siRNA and lays off 500 staffers as Elevidys gets box warning Fierce Biotech
- Sarepta Therapeutics Halts ELEVIDYS Shipments for Non-Ambulatory DMD Patients Yahoo Finance
Source link